Bokf Na Takes $267,000 Position in Medifast, Inc. (NYSE:MED)

Bokf Na bought a new position in shares of Medifast, Inc. (NYSE:MED) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 12,233 shares of the specialty retailer’s stock, valued at approximately $267,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. nVerses Capital LLC increased its position in shares of Medifast by 54.5% during the second quarter. nVerses Capital LLC now owns 1,700 shares of the specialty retailer’s stock worth $37,000 after purchasing an additional 600 shares in the last quarter. CWM LLC lifted its stake in Medifast by 370.8% in the second quarter. CWM LLC now owns 4,684 shares of the specialty retailer’s stock valued at $102,000 after buying an additional 3,689 shares during the last quarter. Swedbank AB acquired a new stake in shares of Medifast in the first quarter valued at approximately $115,000. Virtu Financial LLC purchased a new position in shares of Medifast during the first quarter worth approximately $229,000. Finally, Aigen Investment Management LP increased its holdings in shares of Medifast by 5.7% in the 4th quarter. Aigen Investment Management LP now owns 3,700 shares of the specialty retailer’s stock valued at $249,000 after acquiring an additional 199 shares during the period. Hedge funds and other institutional investors own 95.51% of the company’s stock.

Wall Street Analyst Weigh In

Separately, DA Davidson reissued an “underperform” rating and set a $17.50 price objective on shares of Medifast in a research report on Monday, July 22nd.

Medifast Trading Up 3.0 %

Medifast stock opened at $19.18 on Wednesday. The stock has a 50 day moving average of $19.29 and a two-hundred day moving average of $25.09. Medifast, Inc. has a twelve month low of $17.73 and a twelve month high of $83.60. The stock has a market capitalization of $209.77 million, a price-to-earnings ratio of 3.09 and a beta of 1.13.

Medifast (NYSE:MED) last released its quarterly earnings results on Monday, August 5th. The specialty retailer reported $0.92 EPS for the quarter, topping the consensus estimate of $0.36 by $0.56. Medifast had a return on equity of 25.77% and a net margin of 3.81%. The business had revenue of $168.56 million during the quarter, compared to analysts’ expectations of $160.44 million. During the same quarter in the prior year, the business earned $2.77 earnings per share. Equities analysts predict that Medifast, Inc. will post 1.37 earnings per share for the current year.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.